Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial - Cannon, CP; McCabe, CH; Wilcox, RG; Langer, A; Caspi, A; Berink, P (Circulation, 2000)